The company depends mostly on state and federal gov. health care cost reimbursements. Calif decided to reduce the amount they pay for some of the procedures and there did not seem like there was anything CURE do about it. So everybody is assuming that the fed and all state governments are going to reduce the amount they pay for each treatment and thus believe that CURE's past profitable business may no longer to be the case.
I have bought more thinking that even with the lower payments, the company may streamline its business to make a profit--not at the previous rates but profitable nontheless. it seems to me it should not take too much of an earnings each quarter to sustain Cure as aviable company at least at these prices.